Prestige Consumer Healthcare

PBHNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.217 B

$46.80 +4.07%

Close of 21 Sept 2026

Revenue

$1.09B

#1480 by revenue

Earnings

$190.3M

#1023 by earnings

Shares outstanding

47,374,522

Latest filing cover page

P/E ratio

11.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#96Braveheart BioBRVE$2.25B
#97Generate BiomedicinesGENB$2.23B
#98Prestige Consumer HealthcarePBH$2.22B
#99Palvella TherapeuticsPVLA$2.21B
#100Aurinia PharmaceuticalsAUPH$2.21B

What if Prestige Consumer Healthcare were worth as much as…

Open the what-if tool →

Gold $30.3T

$639,036.61

Per share 13,655× higher

Bitcoin $1.72T

$36,302.29

Per share 776× higher

Nvidia $5.48T

$115,670.99

Per share 2,472× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Prestige Consumer Healthcare are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.